272 related articles for article (PubMed ID: 11024027)
21. AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor.
Nijenhuis WA; Oosterom J; Adan RA
Mol Endocrinol; 2001 Jan; 15(1):164-71. PubMed ID: 11145747
[TBL] [Abstract][Full Text] [Related]
22. Agouti antagonism of melanocortin-4 receptor: greater effect with desacetyl-alpha-melanocyte-stimulating hormone (MSH) than with alpha-MSH.
Mountjoy KG; Willard DH; Wilkison WO
Endocrinology; 1999 May; 140(5):2167-72. PubMed ID: 10218968
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterization of 30 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists, synthetic agonists, and the endogenous agouti-related protein antagonist.
Xiang Z; Proneth B; Dirain ML; Litherland SA; Haskell-Luevano C
Biochemistry; 2010 Jun; 49(22):4583-600. PubMed ID: 20462274
[TBL] [Abstract][Full Text] [Related]
24. Contribution of melanocortin receptor exoloops to Agouti-related protein binding.
Yang YK; Dickinson CJ; Zeng Q; Li JY; Thompson DA; Gantz I
J Biol Chem; 1999 May; 274(20):14100-6. PubMed ID: 10318826
[TBL] [Abstract][Full Text] [Related]
25. Effects of melanocortin receptor activation and blockade on ethanol intake: a possible role for the melanocortin-4 receptor.
Navarro M; Cubero I; Chen AS; Chen HY; Knapp DJ; Breese GR; Marsh DJ; Thiele TE
Alcohol Clin Exp Res; 2005 Jun; 29(6):949-57. PubMed ID: 15976520
[TBL] [Abstract][Full Text] [Related]
26. The interaction of MC3R and MC4R with MRAP2, ACTH, α-MSH and AgRP in chickens.
Zhang J; Li X; Zhou Y; Cui L; Li J; Wu C; Wan Y; Li J; Wang Y
J Endocrinol; 2017 Aug; 234(2):155-174. PubMed ID: 28512117
[TBL] [Abstract][Full Text] [Related]
27. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position.
Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
J Med Chem; 2002 Dec; 45(26):5736-44. PubMed ID: 12477357
[TBL] [Abstract][Full Text] [Related]
28. High-resolution NMR structure of the chemically-synthesized melanocortin receptor binding domain AGRP(87-132) of the agouti-related protein.
McNulty JC; Thompson DA; Bolin KA; Wilken J; Barsh GS; Millhauser GL
Biochemistry; 2001 Dec; 40(51):15520-7. PubMed ID: 11747427
[TBL] [Abstract][Full Text] [Related]
29. Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo.
Ollmann MM; Lamoreux ML; Wilson BD; Barsh GS
Genes Dev; 1998 Feb; 12(3):316-30. PubMed ID: 9450927
[TBL] [Abstract][Full Text] [Related]
30. Discovery of prototype peptidomimetic agonists at the human melanocortin receptors MC1R and MC4R.
Haskell-Luevano C; Hendrata S; North C; Sawyer TK; Hadley ME; Hruby VJ; Dickinson C; Gantz I
J Med Chem; 1997 Jul; 40(14):2133-9. PubMed ID: 9216831
[TBL] [Abstract][Full Text] [Related]
31. Molecular determinants of ligand binding to the human melanocortin-4 receptor.
Yang YK; Fong TM; Dickinson CJ; Mao C; Li JY; Tota MR; Mosley R; Van Der Ploeg LH; Gantz I
Biochemistry; 2000 Dec; 39(48):14900-11. PubMed ID: 11101306
[TBL] [Abstract][Full Text] [Related]
32. Molecular interaction of Agouti protein and Agouti-related protein with human melanocortin receptors.
Tota MR; Smith TS; Mao C; MacNeil T; Mosley RT; Van der Ploeg LH; Fong TM
Biochemistry; 1999 Jan; 38(3):897-904. PubMed ID: 9893984
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe position.
Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
J Med Chem; 2002 Jul; 45(14):3073-81. PubMed ID: 12086493
[TBL] [Abstract][Full Text] [Related]
34. Molecular pharmacology of Agouti protein in vitro and in vivo.
Barsh GS; Ollmann MM; Wilson BD; Miller KA; Gunn TM
Ann N Y Acad Sci; 1999 Oct; 885():143-52. PubMed ID: 10816647
[TBL] [Abstract][Full Text] [Related]
35. Melanocortin peptides stimulate prolactin gene expression and prolactin accumulation in rat pituitary aggregate cell cultures.
Langouche L; Hersmus N; Papageorgiou A; Vankelecom H; Denef C
J Neuroendocrinol; 2004 Aug; 16(8):695-703. PubMed ID: 15271062
[TBL] [Abstract][Full Text] [Related]
36. Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist Profiles.
Ericson MD; Koerperich ZM; Freeman KT; Fleming KA; Haskell-Luevano C
ACS Chem Neurosci; 2018 Dec; 9(12):3015-3023. PubMed ID: 29924583
[TBL] [Abstract][Full Text] [Related]
37. Characterization of melanocortin NDP-MSH agonist peptide fragments at the mouse central and peripheral melanocortin receptors.
Haskell-Luevano C; Holder JR; Monck EK; Bauzo RM
J Med Chem; 2001 Jun; 44(13):2247-52. PubMed ID: 11405661
[TBL] [Abstract][Full Text] [Related]
38. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors. 1. Modifications at the His position.
Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
J Med Chem; 2002 Jun; 45(13):2801-10. PubMed ID: 12061882
[TBL] [Abstract][Full Text] [Related]
39. Effects of melanocortin receptor ligands on thyrotropin-releasing hormone release: evidence for the differential roles of melanocortin 3 and 4 receptors.
Kim MS; Small CJ; Russell SH; Morgan DG; Abbott CR; alAhmed SH; Hay DL; Ghatei MA; Smith DM; Bloom SR
J Neuroendocrinol; 2002 Apr; 14(4):276-82. PubMed ID: 11963824
[TBL] [Abstract][Full Text] [Related]
40. Discovery and in vivo evaluation of new melanocortin-4 receptor-selective peptides.
Nijenhuis WA; Kruijtzer JA; Wanders N; Vrinten DH; Garner KM; Schaaper WM; Meloen RH; Gispen WH; Liskamp RM; Adan RA
Peptides; 2003 Feb; 24(2):271-80. PubMed ID: 12668212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]